Docetaxel (trade name Taxotere) is a clinically well established anti-mitotic chemotherapy medication,
recommended as a possible adjuvant treatment for breast, ovarian, and non-small cell lung cancer. Docetaxel has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. and a European approval for use in -refractory prostate cancer.
Our production capbility is 5 kgs per month.
welcome your inquiry.
Best regards, J. Chen
Contact Name: J. Chen
Company Name: Nowa Pharmceuticals Co., Ltd
Tel: 86-512-69362781 or 86-512-69362785
Fax: 86-512-62527116 or 86-512-69362782
Street Address: 1355 Jinjihu Avenue,
SIP, Suzhou, Jiangsu, China 215021
Member name: nowapharm
Member Since: 02 July 2010
Total Leads: 107 nowapharm Import Export Business Leads
Business focus: Biomedical, Chemical Compounds, Drug Candidates, Mo Sources, Ga (ch3)3, Al (ch3)3, Ga (c2h5)3, In (c2h5)3, Zn (c2h5)2, Docetaxel, Taxotere
Verify: Safe Import Export Tips